Directly observed therapy with primaquine to reduce the recurrence rate of plasmodium vivax infection along the Thai-Myanmar border

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 42, Issue 1, 2011, Pages 9-18

  Maneeboonyang, Wanchai ^a   Lawpoolsri, Saranath ^a   Puangsa Art, Supalarp ^a   Yimsamran, Surapon ^a   Thanyavanich, Nipon ^a   Wuthisen, Pitak ^a   Prommongkol, Sutthiporn ^a   Chaimongkul, Wuthichai ^a   Rukmanee, Prasert ^a   Rukmanee, Natefa ^a   Chavez, Irwin F ^a   Buchachart, Kasinee ^a   Krudsood, Srivicha ^a   Singhasivanon, Pratap ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Drug compliance; Plasmodium vivax; Primaquine; Recurrence rate

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; PRIMAQUINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COMPARATIVE STUDY; DIRECTLY OBSERVED THERAPY; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; INFANT; MALE; MIDDLE AGED; MYANMAR; PATIENT COMPLIANCE; PLASMODIUM VIVAX MALARIA; PRESCHOOL CHILD; RECURRENT DISEASE; STATISTICS; THAILAND;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DIRECTLY OBSERVED THERAPY; FEMALE; HUMANS; INFANT; MALARIA, VIVAX; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MYANMAR; PRIMAQUINE; RECURRENCE; SELF ADMINISTRATION; THAILAND; YOUNG ADULT;

EID: 79953752024     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Baird JK, Leksana B, Masbar S, et al. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Am J Trop Med Hyg 1997; 56: 621-6.
2. Baird JK, Tiwari T, Martin GJ, et al. Chloroquine for the treatment of uncomplicated malaria in Guyana. Ann Trop Med Parasitol 2002; 96: 339-48.
3. Baird JK, Waidy I, Frayauff DJ, et al. In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nibire, Irian Jaya, Indonesia. Am J Trop Med Hyg 1997; 56: 627-31.
4. Burnag D, Karbwang J, Thanavibul A, et al. High dose of primaquine in primaquine resistant vivax malaria. Trans R Soc Trop Med Hyg 1994; 88: 218-9.
5. Chareonviriyaphap T, Bangs MJ, Ratanatham S. Status of malaria in Thailand. Southeast Asian J Trop Med Public Health 2000; 31: 225-37.
6. Colins WE, Jeffery GM. Primaquine resistance in Plasmodium vivax. Am J Trop Med Hyg 1996; 55: 243-9.
7. Dau VK, Kar PK, Sharmar VP. Chloroquine resistant Plasmodium vivax malaria in India. Trop Med Int Health 1996; 1: 816-9.
8. Doherty JF, Day JH, Warhurst DC, Chiodini PL. Treatment of Plasmodium vivax malariatime for a change? Trans R Soc Trop Med Hyg 1997; 91: 76.
9. Duarte EC, Pang LW, Ribeiro LC, Fontes CJF. Association of subtherapeutic dosages of a standard drug regimen with failures in preventing relapses of vivax malaria. Am J Trop Med Hyg 2001; 65: 471-6.
10. Fryauff DJ, Baird JK, Candradikusuma D, et al. Survey of in vivo sensitivity to chloroquine by Plasmodium falciparum and P. vivax in Lombok, Indonesia. Am J Trop Med Hyg 1997; 56: 241-4.
11. Looareesuwan S, Buchachart K, Wilairatana P, et al. Primaquine-tolerant vivax malaria in Thailand. Ann Trop Med Parasitol 1997; 91: 939-43.
12. Looareesuwan S, White NJ, Chittamas S, Bunnag D, Harinasuta T. High rate of Plasmodium vivax relapse following treatment of falciparum malaria Thailand. Lancet 1987; ii: 1052-4.
13. Looareesuwan S, Wilairatana P, Glanarongran R, et al. Atovaquone and proguanil hydrochloride followed by primaquine for treatment of Plasmodium vivax malaria in Thailand. Trans R Soc Trop Med Hyg 1999; 93: 637-40.
14. Luxemburger C, Ricci F, Nosten F, Raimond D, Bathet S, White NJ. The epidemiology of severe malaria in an area of low transmission in Thailand. Trans R Soc Trop Med Hyg 1997; 91: 256-62.
15. Marlar-Than, Myat-Phone-kyaw, Aye-Yu-Soe, Khaing-Khaing-Gyi, Ma-Sabai, Myint-Oo. Development of resistance to chloroquine by Plasmodium vivax in Myanmar. Trans R Soc Trop Med Hyg 1995; 89: 307-8.
16. Mendis K, Sina BJ, Marchesini P, Carter R. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 2001; 64: 97-106.
17. Nandy A, Addy M, Maji AK, Bandyopadhyay AK. Monitoring the chloroquine sensitivity of Plasmodium vivax from Calcutta and Orissa, India. Ann Trop Med Parasitol 2003; 97: 215-20.
18. Nosten F, McGready R, Simpson JA, et al. Effects of Plasmodium vivax malaria in pregnancy. Lancet 1999; 354: 546-9.
19. Phillips EJ, Keystone JS, Kain KC. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. Clin Infect Dis 1996; 23:1171-3.
20. Prasad RN, Virk KJ, Sharma VP. Relapse/reinfection patterns of Plasmodium vivax infection: A four year study. Southeast Asian J Trop Med Public Health 1991; 22: 499-503.
21. Pukrittayakamee S, Chantra A, Simpson JA, et al. Therapeutic responses to different antimalarial drugs in vivax malaria. Antimicrob Agents Chemother 2000; 44: 1680-5.
22. Pukrittayakamee S, Imwong M, Looareesuwan S, White NJ. Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. Acta Trop 2004; 89: 351-6.
23. Silachamroon U, Krudsood S, Treepratsuk S, Wilairatana P, Chalermrult K, Mint HY.Clinical trial of oral Artesunate with or without high-dose Primaquine for the treatment of vivax malaria in Thailand. Am J Trop Med Hyg 2003; 69: 14-8.
24. Singh N, Shukla MM, Sharma VP. Epidemiology of malaria in pregnancy in central India. Bull World Health Organ 1999; 77: 567-72.
25. Srivastava HC, Sharma SK, Bhatt RM, Sharma VP. Studies on Plasmodium vivax relapse pattern in Kheda district, Gujarat. Indian J Malariol 1996; 33: 173-9.
26. Tan-Ariya P, Na-Bangchang K, Tin T, Limpaibul L, Brockelman CR, Karbwang J. Clinical response and susceptibility in vitro of Plasmodium vivax to the standard regimen of chloroquine in Thailand. Trans R Soc Trop Med Hyg 1995; 89: 426-9.
27. Thang ND, Erhart A, Speybroeck N, et al. Malaria in Central Vietnam; analysis of risk factors by multivariate analysis and classification tree models. Malar J 2008; 7: 28.
28. Vitor-silva S, Reyes-Lecca RC, Pinheiro TRA, et al. Malaria is associated with poor school performance in an endemic area of the Brazillan. Malar J 2009; 8: 230.
29. World Health Organization (WHO). Guidelines for the treatment of malaria. 2nd ed. Geneva: WHO, 2010. [Cited 2010 Apr 8]. Available from: URL: http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf
30. Wilairatana P, Silachamroon U, Krudsood S, et al. Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand. Am J Trop Med Hyg 1999; 61: 973-7.
31. Williams TM, Maitland K, Phelps L, et al. Plasmodium vivax:a cause of malnutrition in young children. Oxford J 1997; 90: 751-7.